5 Things You MUST Verify Before Buying ANY Oral BPC-157
Most Brands Fail at #2

We start here because everyone starts here. A COA from a third-party lab is supposed to verify that the powder in the capsule is actually BPC-157, and that it isn't cut with fillers or contaminants. It's a baseline. The bare minimum.

Almost every brand passes this test. The COA on their website matches the peptide. The purity figure clears 99%. So far so good.

Which is exactly why most brands stop at this criterion and hope you do too.

This is the single test that eliminates more BPC-157 brands than any other. It's also the one almost no buyer thinks to ask about.

BPC-157 is a 15-amino-acid peptide. Your stomach is a hydrochloric acid bath. It is specifically designed to shred peptides into individual amino acids.

The two facts are not compatible.

Without protection, swallowing BPC-157 is biochemically equivalent to dissolving sugar in vinegar. By the time it reaches your small intestine, the molecular structure that does the work is gone.

The salt form determines whether the peptide survives.

BPC-157 acetate — the cheaper, more common form — has documented oral bioavailability below 10%. Over 90% of what you swallow is destroyed before it can act.

BPC-157 stabilized as Arginine Salt — also called BPC-157 arginate — survives the digestive transit intact. Bioavailability climbs above 99% in the published characterizations.

Most brands use acetate. Some don't disclose the salt form at all — which usually means acetate. The handful that use Arginine Salt are pharmaceutical-grade operations charging more per bottle. The formulation costs more to make. Molecular stability has to be engineered, not assumed.

If a brand fails Criterion #2, nothing else matters. They could have the prettiest website on the internet. The friendliest customer service. The deepest discount. You're still flushing the active ingredient down the toilet.

This is where the gap between "we tested it" and "an independent lab tested it" gets very wide.

Most brands' COAs answer a single question: is this powder what we say it is? Purity. Identity. That's the standard supplement-industry COA. It's necessary, it's not sufficient.

The deeper question — does this formulation actually deliver the peptide intact through the digestive process? — requires bioavailability testing. Different lab. Different protocol. Different cost. And almost no brand pays for it because they don't have to. Customers don't know to ask.

We expected this criterion to be straightforward. It wasn't.

Several BPC-157 brands market themselves as "Made in USA," display Wyoming or Delaware corporate addresses, run American-flag imagery in their advertising, and ship from Lithuania. Customers find this out when their tracking number first appears with a Vilnius origin. Some find out when their package gets stuck in customs for 30+ days. Some find out when their package never arrives at all.

This is documented at scale. We pulled the public Trustpilot complaints — David G., Tori, Mariza Jorge, Robert T Builder, the BBB Scam Tracker report #1187875 — and the pattern is consistent: order placed, weeks of silence, tracking number eventually appears showing Lithuania Post, package detained at customs, customer support sends template responses, refunds rarely arrive without filing a chargeback.

The reason this matters isn't national pride. It's that peptides are temperature-sensitive, customs delays compound that problem, and a brand willing to obscure where it actually ships from has already shown you how it handles the rest of its operation. The "Made in USA" claim becomes legally interesting when "all or virtually all" manufacturing has to be domestic, and your peptide is being shipped from Vilnius.

BPC-157 is not a same-day-results supplement. The published timelines on tendon repair, gut healing, and tissue regeneration run 4 to 12 weeks before the effect is fully apparent. A 30-day money-back guarantee in this category is, in practical terms, no guarantee at all — your refund window expires before the peptide has had time to do the thing you bought it for.

The other half of this criterion is the subscription pattern. We pulled dozens of complaints describing the same architecture: subscription default-on at checkout (not opt-in), recurring charges showing up before the customer realized they had signed up for one, customer support running an 11-day email loop before processing a cancellation, refunds requiring a chargeback to actually clear.

These are not edge cases. They are an operating model — designed friction that converts undecided one-time buyers into recurring revenue, then makes the recurring revenue expensive to leave.